Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)

F. Conforti; M. Marino; V. Vitolo; L. Spaggiari; R. Mantegazza; P. Zucali; E. Ruffini; L. di Tommaso; G. Pelosi; M. Barberis; I. Petrini; G. Palmieri; G. Pasello; G. Galli; R. Berardi; M. Garassino; P. Filosso; M. Alloisio; M. Scorsetti; R. Orecchia; L. Pala; L. Abatedaga; S. Cinieri; T. De Pas

doi:10.1016/j.esmoop.2021.100188

Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)

F. Conforti, M. Marino, V. Vitolo, L. Spaggiari, R. Mantegazza, P. Zucali, E. Ruffini, L. di Tommaso, G. Pelosi, M. Barberis, I. Petrini, G. Palmieri, G. Pasello, G. Galli, R. Berardi, M. Garassino, P. Filosso, M. Alloisio, M. Scorsetti, R. OrecchiaL. Pala, L. Abatedaga, S. Cinieri, T. De Pas

Istituto Regina Elena

Research output: Contribution to journal › Review article › peer-review

Abstract

The Italian Association of Medical Oncology recommendations on thymic epithelial tumors, which have been drawn up for the first time in 2020 through an evidence-based approach, report indications on all the main aspects of clinical management of this group of rare diseases, from diagnosis and staging, to new available systemic treatments, such as targeted therapies and immunotherapies. A summary of key recommendations is presented here and complete recommendations are reported as Supplementary Materials, available at https://doi.org/10.1016/j.esmoop.2021.100188.

Original language	English
Article number	100188
Journal	ESMO Open
Volume	6
Issue number	4
DOIs	https://doi.org/10.1016/j.esmoop.2021.100188
Publication status	Published - Aug 2021

Keywords

AIOM
recommendations
thymic epithelial tumors

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/j.esmoop.2021.100188

Cite this

Conforti, F., Marino, M., Vitolo, V., Spaggiari, L., Mantegazza, R., Zucali, P., Ruffini, E., di Tommaso, L., Pelosi, G., Barberis, M., Petrini, I., Palmieri, G., Pasello, G., Galli, G., Berardi, R., Garassino, M., Filosso, P., Alloisio, M., Scorsetti, M., ... De Pas, T. (2021). Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM). ESMO Open, 6(4), [100188]. https://doi.org/10.1016/j.esmoop.2021.100188

Conforti, F, Marino, M, Vitolo, V, Spaggiari, L, Mantegazza, R, Zucali, P, Ruffini, E, di Tommaso, L, Pelosi, G, Barberis, M, Petrini, I, Palmieri, G, Pasello, G, Galli, G, Berardi, R, Garassino, M, Filosso, P, Alloisio, M, Scorsetti, M, Orecchia, R, Pala, L, Abatedaga, L, Cinieri, S & De Pas, T 2021, 'Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)', ESMO Open, vol. 6, no. 4, 100188. https://doi.org/10.1016/j.esmoop.2021.100188

@article{eae405bc5853448da6251391fa96eee5,

title = "Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)",

abstract = "The Italian Association of Medical Oncology recommendations on thymic epithelial tumors, which have been drawn up for the first time in 2020 through an evidence-based approach, report indications on all the main aspects of clinical management of this group of rare diseases, from diagnosis and staging, to new available systemic treatments, such as targeted therapies and immunotherapies. A summary of key recommendations is presented here and complete recommendations are reported as Supplementary Materials, available at https://doi.org/10.1016/j.esmoop.2021.100188.",

keywords = "AIOM, recommendations, thymic epithelial tumors",

author = "F. Conforti and M. Marino and V. Vitolo and L. Spaggiari and R. Mantegazza and P. Zucali and E. Ruffini and {di Tommaso}, L. and G. Pelosi and M. Barberis and I. Petrini and G. Palmieri and G. Pasello and G. Galli and R. Berardi and M. Garassino and P. Filosso and M. Alloisio and M. Scorsetti and R. Orecchia and L. Pala and L. Abatedaga and S. Cinieri and {De Pas}, T.",

note = "Funding Information: None declared. The authors have declared no conflicts of interest. Publisher Copyright: {\textcopyright} 2021 The Author(s)",

year = "2021",

month = aug,

doi = "10.1016/j.esmoop.2021.100188",

language = "English",

volume = "6",

journal = "ESMO Open",

issn = "2059-7029",

publisher = "BMJ Publishing Group",

number = "4",

}

TY - JOUR

T1 - Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)

AU - Conforti, F.

AU - Marino, M.

AU - Vitolo, V.

AU - Spaggiari, L.

AU - Mantegazza, R.

AU - Zucali, P.

AU - Ruffini, E.

AU - di Tommaso, L.

AU - Pelosi, G.

AU - Barberis, M.

AU - Petrini, I.

AU - Palmieri, G.

AU - Pasello, G.

AU - Galli, G.

AU - Berardi, R.

AU - Garassino, M.

AU - Filosso, P.

AU - Alloisio, M.

AU - Scorsetti, M.

AU - Orecchia, R.

AU - Pala, L.

AU - Abatedaga, L.

AU - Cinieri, S.

AU - De Pas, T.

PY - 2021/8

Y1 - 2021/8

N2 - The Italian Association of Medical Oncology recommendations on thymic epithelial tumors, which have been drawn up for the first time in 2020 through an evidence-based approach, report indications on all the main aspects of clinical management of this group of rare diseases, from diagnosis and staging, to new available systemic treatments, such as targeted therapies and immunotherapies. A summary of key recommendations is presented here and complete recommendations are reported as Supplementary Materials, available at https://doi.org/10.1016/j.esmoop.2021.100188.

AB - The Italian Association of Medical Oncology recommendations on thymic epithelial tumors, which have been drawn up for the first time in 2020 through an evidence-based approach, report indications on all the main aspects of clinical management of this group of rare diseases, from diagnosis and staging, to new available systemic treatments, such as targeted therapies and immunotherapies. A summary of key recommendations is presented here and complete recommendations are reported as Supplementary Materials, available at https://doi.org/10.1016/j.esmoop.2021.100188.

KW - AIOM

KW - recommendations

KW - thymic epithelial tumors

UR - http://www.scopus.com/inward/record.url?scp=85117623324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85117623324&partnerID=8YFLogxK

U2 - 10.1016/j.esmoop.2021.100188

DO - 10.1016/j.esmoop.2021.100188

M3 - Review article

AN - SCOPUS:85117623324

SN - 2059-7029

VL - 6

JO - ESMO Open

JF - ESMO Open

IS - 4

M1 - 100188

ER -

Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this